KARA HOMMERDING: Open Payments
NPI 1760600159 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 37 payments from 11 companies in 2025. Trend: 2023 $1,308 · 2024 $898 · 2025 $993
Food & beverage: $811Education: $182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $282 |
| GENZYME CORPORATION | 7 | $206 |
| Organon LLC | 7 | $100 |
| UCB, Inc. | 2 | $83 |
| ABBVIE INC. | 3 | $73 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Incyte Corporation | 2 | $36 |
| Galderma Laboratories, L.P. | 1 | $28 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Zoryve, Rhapsido, RINVOQ, Cabtreo, OPZELURA.
Industry payments across CO — which companies pay providers there.
